The mTOR pathway in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Signal Transduction

Background:

• Cancer development is linked to numerous mutations affecting signal transduction proteins.
• Aberrant activation of the mammalian target of rapamycin (mTOR) kinase signaling pathway is common in various human cancers.
• Targeted cancer therapy aims to utilize molecular alterations for personalized treatment selection.

Purpose of the Study:

• To review the mammalian target of rapamycin (mTOR) signaling pathway.
• To discuss mechanisms of mTOR pathway activation in cancer.
• To examine the therapeutic potential of mTOR inhibitors in breast cancer.

Main Methods:

• Literature review of current research on mTOR signaling in cancer.
• Analysis of molecular mechanisms underlying mTOR pathway activation.
• Evaluation of preclinical and clinical data on mTOR inhibitors in breast cancer.

Main Results:

• The mTOR pathway plays a critical role in cell growth, proliferation, and survival.
• Dysregulation of mTOR signaling contributes to tumorigenesis across multiple cancer types.
• Inhibitors targeting the mTOR pathway show promise in preclinical models of breast cancer.

Conclusions:

• Understanding mTOR pathway activation is crucial for developing targeted cancer therapies.
• mTOR inhibitors represent a potential therapeutic strategy for breast cancer patients.
• Further research is needed to optimize the use of mTOR inhibitors in clinical practice.